Skip to main content
Caplight Logo









PM Biomaterials

PM Biomaterials

Private
TurkeyEnergy & Sustainabilityhttps://pmbiomaterials.com/

Last Round

VC Round

Jul 19, 2023

Est. Valuation

$10M

Total Funding Raised

$150,000

Company Overview

PM Biomaterials is a bioplastics company that produces high-performance biopolymers by converting starch-based food waste.

Sector

Energy & Sustainability

Verticals

Advanced Materials, Sustainable Materials, Circular Economy, Clean Manufacturing, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

biopolymersbioplasticsbiopolymer resinssustainable materialsbio-based materialsplastic replacementstarch-based biopolymersdrop-in replacementupcycled materialscircular economywaste valorizationinjection molding materialsextrusion materialssustainable packagingautomotive bioplasticsISCC PLUS certification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PM Biomaterials Comparables

Compare PM Biomaterials with similar companies based on industry and business-model similarity.

PM Biomaterials comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biolive
89%
Sulapac
85%
traceless materials
84%

PM Biomaterials Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 19, 2023
SeedMar 8, 2022

PM Biomaterials Investors

Notable investors and investment history

PM Biomaterials investors
InvestorRounds
Workup Girişimcilik ProgramıSeed
Hamdi Ulukaya InitiativeSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 19, 2023

    Raised $10M post-money round with The Purest Solutions.

  • Mar 8, 2022

    $150K round with participation from Hamdi Ulukaya Initiative.

PM Biomaterials Filings

Explore SEC and related filing metadata, where available.

PM Biomaterials filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PM Biomaterials's valuation, stock price, and market status.

Is PM Biomaterials a public or private company?

PM Biomaterials is a private company.

What is the current stock price of PM Biomaterials?

PM Biomaterials is a private company with no public stock price. No recent secondary market data is available.

How much is PM Biomaterials worth (valuation)?

PM Biomaterials's valuation is estimated at $10.0M based on funding round data.

Can I buy PM Biomaterials stock?

PM Biomaterials shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PM Biomaterials's last funding round?

PM Biomaterials's most recent funding round was VC Round on July 19, 2023.

Who are the main investors in PM Biomaterials?

Key investors in PM Biomaterials include Workup Girişimcilik Programı, Hamdi Ulukaya Initiative.

Will PM Biomaterials IPO soon?

No public IPO plans have been announced for PM Biomaterials.

How can I track PM Biomaterials secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PM Biomaterials's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTurkey
Year Founded2021
Last FundingJul 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?